Document

Adult Heart and HeartLung Status 2 Criteria 5 Extension Justification Form Medical Urgency Data

ICR 202506-0915-004 · OMB 0915-0157 · Object 159416901.

Document Viewer [xlsx]

Status: Original and derived artifacts are available for this document.

Download: xlsx | pdf | html

Primary: spreadsheetSource: application/vnd.openxmlformats-officedocument.spreadsheetml.sheet
Loading document viewer…

Document Metadata

Record metadata
application/vnd.openxmlformats-officedocument.spreadsheetml.sheet
Adult Heart and HeartLung Status 2 Criteria 5 Extension Justification Form Medical Urgency Data
Calc
2024-11-20
2026-10-03
complete

Extracted Text

Adult Heart and HeartLung Status 2 Criteria 5 Extension Justification Form Medica
Fields to be completed by members
Form Section
Status 2 Extension
Criteria 5
Status 2 Extension
Criteria 5
Status 2 Extension
Criteria 5
Status 2 Extension
Criteria 5
Status 2 Extension
Criteria 5
Status 2 Extension
Criteria 5
Status 2 Extension
Criteria 5
Status 2 Extension
Criteria 5
Status 2 Extension
Criteria 5
Status 2 Extension
Criteria 5
Status 2 Extension
Criteria 5
Status 2 Extension
Criteria 5
Status 2 Extension
Criteria 5

Field Label
Intra-aortic balloon pump
Hemodynamic measurements were obtained
and within 24 hour period
Cardiac index
Cardiac index - Test Date
Cardiac index - Test Time
Pulmonary capillary wedge pressure
Pulmonary capillary wedge pressure - Test
Date
Pulmonary capillary wedge pressure - Test
Time
Systolic blood pressure
Systolic blood pressure - Test Date
Systolic blood pressure - Test Time
Select one of the following, the candidate
either
Was being supported by inotropic therapy
according to either of the following qualifying
doses
A continuous infusion of at least one high
dose intravenous inotrope
A continuous infusion of at least two
intravenous inotropes
Developed ventricular tachycardia lasting at
least 30 seconds or required cardioversion,
defibrillation, or antitachycardia pacing after
inotropic therapy was initiated in an attempt to
reach the qualifying doses
Hemodynamic measurements were not
obtained. However, within 24 hours prior to
IABP support
Date of administration of CPR

Status 2 Extension
Criteria 5
Status 2 Extension
Criteria 5
Status 2 Extension
Criteria 5

Status 2 Extension
Criteria 5
Status 2 Extension
Criteria 5
Status 2 Extension
Criteria 5
Status 2 Extension
Criteria 5

Date of administration of CPR - Test Time
Systolic blood pressure

_x000D_ OPTN Restricted
#

Status 2 Extension
Criteria 5
Status 2 Extension
Criteria 5
Status 2 Extension
Criteria 5
Status 2 Extension
Criteria 5
Status 2 Extension
Criteria 5
Status 2 Extension
Criteria 5
Status 2 Extension
Criteria 5
Status 2 Extension
Criteria 5
Status 2 Extension
Criteria 5
Status 2 Extension
Criteria 5
Status 2 Extension
Criteria 5
Status 2 Extension
Criteria 5
Status 2 Extension
Criteria 6
Status 2 Extension
Criteria 5
Status 2 Extension
Criteria 5
Status 2 Extension
Criteria 5
Status 2 Extension
Criteria 5
Status 2 Extension
Criteria 5
Status 2 Extension
Criteria 5
Status 2 Extension
Criteria 5
Status 2 Extension
Criteria 5
Status 2 Extension
Criteria 5
Status 2 Extension
Criteria 5
Status 2 Extension
Criteria 5
Status 2 Extension
Criteria 5

Systolic blood pressure - Test Date
Systolic blood pressure - Test Time
Arterial lactate
Arterial lactate - Test Date
Arterial lactate - Test Time
Aspartate transaminase
Aspartate transaminase - Test Date
Aspartate transaminase - Test Time
Alanine transaminase
Alanine transaminase - Test Date
Alanine transaminase - Test Time
Clinical Narrative
Select one of the following
Mean arterial pressure
Mean arterial pressure - Test Date
Mean arterial pressure - Test Time
Cardiac index
Cardiac index - Test Date
Cardiac index - Test Time
Pulmonary capillary wedge pressure
Pulmonary capillary wedge pressure - Test
Date
Pulmonary capillary wedge pressure - Test
Time
SvO2
SvO2 - Test Date
SvO2 - Test Time

_x000D_ OPTN Restricted
#

Status 2 Extension
Criteria 5

Within 48 hours prior to the status expiring,
the candidate was being supported by
inotropic therapy according to either of the
following qualifying doses:
A continuous infusion of at least one high
dose intravenous inotrope
A continuous infusion of at least two
intravenous inotropes

Status 2 Extension
Criteria 5
Status 2 Extension
Criteria 5

OMB No. 0915-0157; Expiration Date: XX/XX/20XX
PUBLIC BURDEN STATEMENT:
The private, non-profit Organ Procurement and Transplantation Network (OPTN) collects this information in order t
functions: to assess whether applicants meet OPTN Bylaw requirements for membership in the OPTN; and to monit
organizations with OPTN Obligations. An agency may not conduct or sponsor, and a person is not required to respo
unless it displays a currently valid OMB control number. The OMB control number for this information collection is
XX/XX/202X. This information collection is required to obtain or retain a benefit per 42 CFR §121.11(b)(2). All data c
Act protection (Privacy Act System of Records #09-15-0055). Data collected by the private non-profit OPTN also are
Contractor’s security features. The Contractor’s security system meets or exceeds the requirements as prescribed b
Security of Federal Automated Information Systems, and the Departments Automated Information Systems Securit
reporting burden for this collection of information is estimated to average 0.27 hours per response, including the ti
searching existing data sources, and completing and reviewing the collection of information. Send comments regar
other aspect of this collection of information, including suggestions for reducing this burden, to HRSA Information C
Fishers Lane, Room 14N39, Rockville, Maryland, 20857 or [email protected].

_x000D_ OPTN Restricted
#

tification Form Medical Urgency Data
mbers
Notes
Display only
Display only
Display only
Display only
Display only
Display only
Display only
Display only
Display only
Display only
Display only
Display only
Display only
Display only
Display only
Display only

Display only
Display only
Display only
Display only

_x000D_ OPTN Restricted
#

Display only
Display only
Display only
Display only
Display only
Display only
Display only
Display only
Display only
Display only
Display only

_x000D_ OPTN Restricted
#

this information in order to perform the following OPTN
n the OPTN; and to monitor compliance of member
n is not required to respond to, a collection of information
information collection is 0915-0157 and it is valid until
R §121.11(b)(2). All data collected will be subject to Privacy
non-profit OPTN also are well protected by a number of the
uirements as prescribed by OMB Circular A-130, Appendix III,
ormation Systems Security Program Handbook. The public
response, including the time for reviewing instructions,
on. Send comments regarding this burden estimate or any
en, to HRSA Information Collection Clearance Officer, 5600

_x000D_ OPTN Restricted
#